🇺🇸 FDA
Pipeline program

GLPG2451 multiple dose

GLPG2451-CL-105

Phase 1 small_molecule completed

Quick answer

GLPG2451 multiple dose for Healthy is a Phase 1 program (small_molecule) at Lakefront Biotherapeutics NV with 1 ClinicalTrials.gov record(s).

Program details

Company
Lakefront Biotherapeutics NV
Indication
Healthy
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials